Norris Medicines Limited (BOM:524414)

Norris Medicines Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-2.81	-12.37	-11.87	-17.49	-32.63
Depreciation & Amortization	4.91	5.37	5.71	6.3	6.57
Loss (Gain) From Sale of Assets	-	-	0.22	-	-
Other Operating Activities	4.8	4.81	4.47	20.45	25.49
Change in Accounts Receivable	2.35	-3.48	0.4	-0.08	6.96
Change in Inventory	1.44	2.05	-11.35	-7.78	26.82
Change in Accounts Payable	-6.25	9.24	15.21	9.21	-49.1
Change in Other Net Operating Assets	1.33	-0.51	-1.1	1.39	5.81
Operating Cash Flow	5.78	5.1	1.7	12	-10.09
Operating Cash Flow Growth	13.24%	200.42%	-85.85%	-	-

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-0.1	-0.19	-0.01	-0.3	-0.55
Sale of Property, Plant & Equipment	-	-	0.91	-	-
Investment in Securities	-	-0	-	-	-
Other Investing Activities	-0.71	0.15	-0.39	0.08	-0.34
Investing Cash Flow	-0.81	-0.04	0.51	-0.22	-0.89

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	-	-	1.67	3.24	25.78
Long-Term Debt Repaid	-0.15	-0.64	-	-	-
Net Debt Issued (Repaid)	-0.15	-0.64	1.67	3.24	25.78
Other Financing Activities	-5	-4.4	-3.7	-15	-14.82
Financing Cash Flow	-5.15	-5.04	-2.03	-11.76	10.96

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-
Net Cash Flow	-0.18	0.02	0.17	0.02	-0.02

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	5.68	4.91	1.69	11.7	-10.65
Free Cash Flow Growth	15.67%	191.17%	-85.58%	-	-
Free Cash Flow Margin	6.98%	8.44%	2.99%	13.99%	-11.28%
Free Cash Flow Per Share	0.57	0.49	0.17	1.17	-1.06
Levered Free Cash Flow	2.2	3.9	2.36	1.26	-18.35
Unlevered Free Cash Flow	5.32	6.53	4.65	10.56	-9.14

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	5	4.4	3.7	15	14.82
Change in Working Capital	-1.13	7.3	3.16	2.75	-9.52

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error